随着减重药巨头诺和诺德重磅GLP-1类药物司美格鲁肽在中国的核心分子专利即将于3月到期，一大批中国本土的司美格鲁肽仿制药正在获批路上。据公开信息，目前国内市场上包括九源基因、丽珠集团、华东医药、齐鲁制药、正大天晴在内的十多家本土制药公司的司美格鲁肽仿制药有望在不久的将来上市，还有十余款处于三期临床，一场价格大战即将席卷。一位内分泌专家表示，随着更多仿制药的上市，减重药很快就会迎来“白菜价”时代。（第一财经）
After you've completed the steps above, you can share your affiliate links in your blog post. You can view performance reports for your affiliate links by visiting the CJ account dashboard. Click "Clients" to see details about clicks, sales, and commissions earned by each client.
，这一点在heLLoword翻译官方下载中也有详细论述
Gavin Arm and Bert de Wit introduced four-day working weeks at their business in 2019
�@�����ăV���b�^�[�����ƃt�@�C���_�[���̃~���[�������Ă��̌����C���[�W�Z���T�[�ɓ��ĂĎB�e�����Ƃ����d�g�݁B
高精度往往意味着低效率—这是目前精密金属打印面临的行业共性难题。